We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Teikoku Pharma reached an agreement with 22 state attorneys general to end a lawsuit accusing the drugmaker of obstructing generic competition. Read More
The FDA is working with providers, manufacturers and distributors to head off potential saline shortages during flu season, FDA Commissioner Scott Gottlieb said Thursday. Read More
The Association for Accessible Medicines’ Biosimilars Council submitted an amicus brief supporting Pfizer in its antitrust lawsuit against Johnson & Johnson, arguing the company’s practices will keep biologics prices high and limit competition from biosimilars. Read More
Eighteen Democratic senators joined Health, Labor, Education and Pensions Committee Ranking Member Patty Murray (Wash.) in calling on the Government Accountability Office to review the Trump administration’s efforts against the opioid addiction crisis. Read More
The FDA proposed a new tactic in its fight against the opioid epidemic — blister packs of smaller quantities of opioid drugs that could give providers better prescription options, especially for drugs like Vicodin and Percocet usually intended for short-term use. Read More
The initiative follows previous joint efforts between the two groups that have saved participating drug plans more than CA$1 billion, or about $810 million U.S., in the last five years. Read More
In testimony before a House subcommittee Tuesday, FDA Commissioner Scott Gottlieb told lawmakers the FDA’s plans for regulating compounding pharmacies, including adapting GMP and oversight standards to a facility’s level of risk. Read More